The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), according to The New York Times.

USAID is in charge of ordering the drugs used by the President's Emergency Plan for AIDS Relief (PEPFAR) in its programs that keep 20 million people with HIV alive, Gawande said. This work stoppage means that pharmacy stocking in more than 25 countries suddenly stops, as do payments to partner organizations, which are mostly locally run.

In the first week after his inauguration, President Donald Trump has stopped funding for PEPFAR, the President’s Emergency Plan for AIDS Relief, jeopardizing the lives of people who receive HIV prevention and treatment through the global aid program.

As a result of the new administration's actions, health centers funded by PEPFAR, the U.S. President's Emergency Plan for AIDS Relief, are closing their doors and no longer dispersing medication.